Unmet needs and treatment of relapsing-remitting multiple sclerosis in saudi arabia: focus on the role of ofatumumab
Treatment-pattern data suggest that some patients with multiple sclerosis (MS) in
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Treatment-pattern data suggest that some patients with multiple sclerosis (MS) in
Background/Objective: Fatigue, cognitive and affective disorders are relevant symptoms in Multiple
trials of immunoglobulin demonstrated remarkable clinical effects in several types of MS, especially in relapsing-remitting type. It is an approved method for the treatment of relapsing-remitting MS that ... therapy…
development of neurological symptoms. Most MS cases are characterized by a relapsing-remitting course, and current therapies rely only on the use of immunomodulating drugs which are, however, unable ... only a very…
Background: Multiple sclerosis (MS) is a chronic demyelinating disorder of the central nervous system. Relapsing-Remitting MS (RRMS) is the most common type of MS that accounts
LoPresti (2015) determined the cognitive abilities of mice with relapsing-remitting experimental autoimmune encephalomyelitis (EAE) treated with and without glatiramer acetate (GA) compared with naïve mice. We found…
Objective: It is widely accepted that working memory (WM) impairment has a
less certain. The objective of this study was to determine the natural history of relapsing-remitting multiple sclerosis, both treated and untreated, in a real-world setting. Methods: We analyzed ... prolonged therapy…
exploration, offering a detailed and comprehensive perspective on the cost-effectiveness of GA for Relapsing-Remitting Multiple Sclerosis (RRMS) from the standpoint of the UK National Health Service
Objective: Fingolimod, a second-line therapy for relapsing-remitting multiple sclerosis, may cause transitory effects on heart rate and atrioventricular conduction that may result in bradycardia and atrioventricular…
compare the cost–effectiveness of different disease-modifying therapies’ strategies for treatment of relapsing-remitting multiple sclerosis (RRMS) (Figure 1). Methods: A Markov model was developed to assess the cost
objective is to describe basal characteristics and effectiveness of fingolimod in patients with relapsing-remitting multiple sclerosis (RRMS) followed for ≥12 months in routine clinical practice in Spain. Methods…
morphology, flexibility and body balance among RRMS patients. Methods: Twenty-two subjects affected by relapsing-remitting multiple sclerosis (RRMS, EDSS ≤ 6) were randomly divided into 3 groups whose members each
benefit from antiretroviral therapy. We report the case of a woman suffering from relapsing-remitting MS (RR-MS) who contracted HIV-1 Infection while she was treated with low-dose
glatiramer acetate (GA) in clinical practice. Methods: A prospective cohort study carried out in relapsing-remitting MS patients starting GA as first-line treatment. Patient information on QoL (Multiple Sclerosis
behavioral variables in the transtheoretical model of change. Methods: Patients diagnosed with relapsing-remitting multiple sclerosis and being treated with GA for the first time, whether treatment-naïve
present study assessed odour threshold, discrimination and identi fi cation in relapsing-remitting MS (RRMS) pa- tients. We administered the Snif fi n’ Sticks Extended Test (Burghart Messtechnik GmbH, Wedel
Introduction: Once-daily Fingolimod (GilenyaÃ?®, Novartis Pharma AG) is a sphingosine 1
Background: Relapse-remitting multiple sclerosis is a chronic disorder that affects more
The current research assessed how digital clock drawing test (dCDT) parameters compliment
For authors and organisers
Find the right journal for your paper and submit your manuscript.